The global healthcare company has chosen ENGIE to support the decarbonization of its industrial sites in France. A Biomethane Purchase Agreement (BPA) aims to decarbonize 56% of Sanofi’s gas consumption in France, starting this year.
The teams at GEMS, ENGIE’s energy management entity, have designed a six-year energy supply contract for the pharmaceutical group, covering 1.3 terawatt-hours (TWh), along with an additional 10-year contract covering 110 GWh to specifically decarbonize Sanofi’s Lyon site.
The six-year contract offers Sanofi a unique combination of flexibility, competitiveness, and sustainability.
A biomethanation unit in France
Sanofi and ENGIE have a long history of collaboration on electricity and gas supply in France, Spain, Italy, Poland, and Belgium. Sanofi was the first industrial client to trust GEMS for a biomethane agreement in 2021. Additionally, the pharmaceutical group has just signed two Power Purchase Agreements (PPAs) with ENGIE for decarbonized electricity: the first covering 1.5 TWh of wind and solar power in France; the second covering 300 GWh of onshore wind power in Belgium.
As the leading biomethane midstreamer in France, GEMS has already signed BPAs with major industrial players, including Arkema in 2023, and BASF and Veolia in 2024.
A Biomethane Purchase Agreement (BPA) is a contract between a biomethane producer and a client, outlining the terms for purchasing biomethane over multiple years. It is the gas equivalent of Power Purchase Agreements (PPAs), which are contracts for buying electricity.
For more details, watch this explainer video:
